ClinicalTrials.gg
Not yet recruitingNCT07774494Updated Aug 20, 2026

Effect of AI-Assisted Discharge Education on Parents of Children With Bronchitis/Bronchiolitis

An interventional study of AI-Assisted Written Discharge Education and AI-Assisted Video Discharge Education in Bronchiolitis and Bronchitis, sponsored by Osmaniye Korkut Ata University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by Osmaniye Korkut Ata University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Sex
Female
01

Study summary

This randomized controlled trial aims to evaluate the effects of artificial intelligence-assisted discharge education on mothers of children hospitalized with bronchitis/bronchiolitis. A total of 162 mothers will be randomly assigned to one of three groups: AI-assisted written discharge education, AI-assisted video discharge education, or routine discharge education. The primary outcome will be mothers' knowledge of home care after discharge. Secondary outcomes will include anxiety, readiness for hospital discharge, and satisfaction with discharge education. The study hypothesizes that AI-assisted written and video discharge education will improve mothers' knowledge and readiness for discharge, reduce anxiety, and increase satisfaction compared with routine discharge education.

Read the detailed description

This is a three-arm, parallel-group, pretest-posttest randomized controlled trial. Mothers who meet the eligibility criteria will be randomized in a 1:1:1 ratio after baseline assessments. The written education group will receive AI-assisted written discharge education, the video education group will receive AI-assisted video discharge education covering the same learning objectives, and the control group will receive routine discharge education.

Knowledge, anxiety, and readiness for hospital discharge will be assessed at baseline and before discharge. Satisfaction with discharge education will be assessed after the intervention. In the two experimental groups, routine discharge education will be provided after completion of the posttest and before hospital discharge.

02

Conditions studied

  • Bronchiolitis
  • Bronchitis

Keywords

  • Artificial Intelligence
  • Mothers
  • Patient Education
  • Readiness for Hospital Discharge
  • Health Education
03

In context

Bronchiolitis

289 studies on the registry are indexed under Bronchiolitis; 51 are open to participants now.

This study's planned enrollment of 144 is above the median of 100 across 195 interventional studies indexed under Bronchiolitis.

Browse Bronchiolitis studies →

Lead sponsor

Osmaniye Korkut Ata University is the lead sponsor of 35 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mother of a child hospitalized with a diagnosis of bronchitis/bronchiolitis
  • Child hospitalized for at least 3 days
  • Willing to participate and provide
  • Able to read and understand Turkish and communicate sufficiently to complete the study forms
  • Owns a smartphone

Exclusion criteria

Exclusion Criteria:

  • Unable to read/view the educational materials or complete the study forms
  • Child requiring intensive care, experiencing severe clinical deterioration, or having a condition preventing completion of the study
  • Child with an additional chronic disease or special care needs
  • Mother who is a healthcare professional
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
144 participants (estimated)

Study arms

  • Experimental
    AI-Assisted Written Discharge Education

    Mothers will receive AI-assisted written discharge education on home care after discharge for children with bronchitis/bronchiolitis. After completion of the posttest, routine discharge education will be provided before hospital discharge.

    Behavioral: AI-Assisted Written Discharge Education

  • Experimental
    AI-Assisted Video Discharge Education

    Mothers will receive AI-assisted video discharge education covering the same learning objectives as the written education. After completion of the posttest, routine discharge education will be provided before hospital discharge.

    Behavioral: AI-Assisted Video Discharge Education

  • Active comparator
    Routine Discharge Education

    Mothers will receive the institution's routine discharge education before the posttest.

    Behavioral: Routine Discharge Education

Interventions

  • BehavioralAI-Assisted Written Discharge Education

    A written discharge education booklet developed with support from ChatGPT based on standard discharge content and expert review.

  • BehavioralAI-Assisted Video Discharge Education

    A video discharge education intervention developed with support from Gemini Notebook and designed to cover the same learning objectives as the written material.

  • BehavioralRoutine Discharge Education

    Standard discharge education routinely provided by the institution.

06

What researchers measure

Primary outcomes

  1. Change in Maternal Knowledge Score Regarding Home Care After Discharge

    Maternal knowledge will be assessed using a 10-item true/false knowledge test developed according to the content of the discharge education. Each correct answer is scored as 1 and each incorrect answer as 0, yielding a total score ranging from 0 to 10. Higher scores indicate greater knowledge.

    Time frame: Baseline before randomization and at hospital discharge, during the same hospitalization.

Secondary outcomes

  1. Change in Readiness for Hospital Discharge

    Readiness for hospital discharge will be assessed using the 26-item Pediatric Readiness for Hospital Discharge Scale (Ped-RHDS). Higher scores indicate greater readiness for hospital discharge.

    Time frame: Baseline before randomization and at hospital discharge, during the same hospitalization

  2. Change in Maternal Anxiety Level

    Maternal anxiety will be assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no anxiety and 10 indicates the highest level of anxiety. Higher scores indicate greater anxiety.

    Time frame: Baseline before randomization and at hospital discharge, during the same hospitalization.

  3. Maternal Satisfaction With Discharge Education

    Satisfaction with discharge education will be assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, with higher scores indicating greater satisfaction with the discharge education.

    Time frame: At hospital discharge, during the same hospitalization.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to participant confidentiality and data protection considerations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jun 2027, 8 months later.

Of 54 non-industry interventional studies with no phase under Bronchiolitis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 8 months is below that.

Counting every sponsor, half of 57 studies reached it within 22 months; a quarter within 11 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2026
First posted
Aug 19, 2026
StartEst.
Oct 15, 2026
Primary completionEst.
Jun 15, 2027
CompletionEst.
Jun 30, 2027
Last update
Aug 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07774494
Lead sponsor
Osmaniye Korkut Ata University
Responsible party
Mustafa KARA (Assistant Profesor, Osmaniye Korkut Ata University) — Principal investigator
First posted
Aug 19, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Jun 15, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Aug 20, 2026

Study contacts

Mustafa KARA, Phd
Contact
mustafaakara@hotmail.com
+905059777429

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion